274 related articles for article (PubMed ID: 2339119)
1. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.
Schaible UE; Kramer MD; Eichmann K; Modolell M; Museteanu C; Simon MM
Proc Natl Acad Sci U S A; 1990 May; 87(10):3768-72. PubMed ID: 2339119
[TBL] [Abstract][Full Text] [Related]
2. A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection.
Schaible UE; Wallich R; Kramer MD; Museteanu C; Simon MM
Behring Inst Mitt; 1991 Feb; (88):59-67. PubMed ID: 2049047
[TBL] [Abstract][Full Text] [Related]
3. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
[TBL] [Abstract][Full Text] [Related]
4. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.
Simon MM; Schaible UE; Kramer MD; Eckerskorn C; Museteanu C; Müller-Hermelink HK; Wallich R
J Infect Dis; 1991 Jul; 164(1):123-32. PubMed ID: 1829104
[TBL] [Abstract][Full Text] [Related]
5. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone.
Schaible UE; Wallich R; Kramer MD; Nerz G; Stehle T; Museteanu C; Simon MM
Int Immunol; 1994 May; 6(5):671-81. PubMed ID: 8080839
[TBL] [Abstract][Full Text] [Related]
6. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.
Schaible UE; Gern L; Wallich R; Kramer MD; Prester M; Simon MM
Immunol Lett; 1993 May; 36(2):219-26. PubMed ID: 8349316
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.
Simon MM; Schaible UE; Wallich R; Kramer MD
Immunol Today; 1991 Jan; 12(1):11-6. PubMed ID: 2015043
[TBL] [Abstract][Full Text] [Related]
9. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis.
Schaible UE; Kramer MD; Museteanu C; Zimmer G; Mossmann H; Simon MM
J Exp Med; 1989 Oct; 170(4):1427-32. PubMed ID: 2794862
[TBL] [Abstract][Full Text] [Related]
10. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R
Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic passive vaccination against chronic Lyme disease in mice.
Zhong W; Stehle T; Museteanu C; Siebers A; Gern L; Kramer M; Wallich R; Simon MM
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12533-8. PubMed ID: 9356484
[TBL] [Abstract][Full Text] [Related]
12. Murine Lyme borreliosis: route of inoculation determines immune response and infectivity.
Pachner AR; Delaney E; Ricalton NS
Reg Immunol; 1992; 4(6):345-51. PubMed ID: 1297405
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
14. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis.
Fikrig E; Bockenstedt LK; Barthold SW; Chen M; Tao H; Ali-Salaam P; Telford SR; Flavell RA
J Infect Dis; 1994 Mar; 169(3):568-74. PubMed ID: 8158028
[TBL] [Abstract][Full Text] [Related]
15. The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator.
Kramer MD; Wallich R; Simon MM
Infection; 1996; 24(2):190-4. PubMed ID: 8740121
[TBL] [Abstract][Full Text] [Related]
16. A recombinant vaccine for Lyme disease.
Wallich R; Kramer MD; Simon MM
Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
[TBL] [Abstract][Full Text] [Related]
17. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
[TBL] [Abstract][Full Text] [Related]
18. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
[TBL] [Abstract][Full Text] [Related]
19. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
20. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis.
Schaible UE; Kramer MD; Wallich R; Tran T; Simon MM
Eur J Immunol; 1991 Oct; 21(10):2397-405. PubMed ID: 1915553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
